(Total Views: 199)
Posted On: 12/08/2024 7:34:44 AM
Post# of 591
Uplisting submission then FDA reply to IDE...
Schedule 13D is a form that must be filed with the U.S. Securities and Exchange Commission (SEC) when a person or group acquires more than 5% of a voting class of a company's equity shares. Schedule 13D must be filed within 10 days of the filer reaching a 5% stake.
https://app.quotemedia.com/data/downloadFilin...2024-12-04
"On November 29th, the company submitted to the FDA an Investigational Device Exemption application (IDE), the approval of which is a precondition to enroll patients in the planned study."
PPS should see a nice bump upon both of these not withstanding capital funding influx to support the clinical research news?
$5-$10+
Schedule 13D is a form that must be filed with the U.S. Securities and Exchange Commission (SEC) when a person or group acquires more than 5% of a voting class of a company's equity shares. Schedule 13D must be filed within 10 days of the filer reaching a 5% stake.
https://app.quotemedia.com/data/downloadFilin...2024-12-04
"On November 29th, the company submitted to the FDA an Investigational Device Exemption application (IDE), the approval of which is a precondition to enroll patients in the planned study."
PPS should see a nice bump upon both of these not withstanding capital funding influx to support the clinical research news?
$5-$10+
(0)
(0)
